Back to Journals » OncoTargets and Therapy » Volume 16

Case report

Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer

       
Total article views   HTML views PDF downloads Totals
2,182 Dovepress* 2,073+ 57 2,130
PubMed Central* 109 34 143
Totals 2,182 91 2,273
*Since 29 November 2023

View citations on PubMed Central and Google Scholar